TIDMGSK

RNS Number : 9957Y

GlaxoSmithKline PLC

19 January 2022

   GlaxoSmithKline plc   (the ' Company ') 

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                   Ms E Walmsley 
====  ======================================  ==================================================== 
 b)    Position/status                        Chief Executive Officer 
====  ======================================  ==================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ==================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ==================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 13 January 2022 
                                               on Ordinary Shares held in the Company's 
                                               Deferred Annual Bonus Plan 
====  ======================================  ==================================================== 
 c)    Price(s) and                           Price(s)                    Volume(s) 
        volume(s) 
====  ======================================  ==========================  ====================== 
                                              GBP16.3120                  832 
 ===========================================  ==========================  ====================== 
                                              GBP16.3120                  669 
                                              ==========================  ====================== 
                                              GBP16.3120                  557 
                                              ==========================  ====================== 
 
 d)    Aggregated information                 2,058 
==== 
 
    Aggregated volume                           GBP16.3120 
    Price 
 ===========================================  ==================================================== 
 e)    Date of the transaction                2022-01-17 
====  ======================================  ==================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                   Mr I Mackay 
====  ======================================  ==================================================== 
 b)    Position/status                        Chief Financial Officer 
====  ======================================  ==================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ==================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ==================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 13 January 2022 
                                               on Ordinary Shares held in the Company's 
                                               Deferred Annual Bonus Plan 
====  ======================================  ==================================================== 
 c)    Price(s) and                           Price(s)                    Volume(s) 
        volume(s) 
====  ======================================  ==========================  ====================== 
                                              GBP16.3120                  452 
 ===========================================  ==========================  ====================== 
                                              GBP16.3120                  386 
                                              ==========================  ====================== 
 
 d)    Aggregated information                 838 
==== 
 
    Aggregated volume                           GBP16.3120 
    Price 
 ===========================================  ==================================================== 
 e)    Date of the transaction                2022-01-17 
====  ======================================  ==================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                    Dr H Barron 
====  =======================================  =================================================== 
 b)    Position/status                         Chief Scientific Officer and President, 
                                                R&D 
====  =======================================  =================================================== 
 c)    Initial notification/                   Initial notification 
        amendment 
====  =======================================  =================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                    GlaxoSmithKline plc 
====  =======================================  =================================================== 
 b)    LEI                                     5493000HZTVUYLO1D793 
====  =======================================  =================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                          American Depositary Shares ('ADSs') 
        the financial                           ISIN: US37733W1053 
        instrument 
====  =======================================  =================================================== 
 b)    Nature of the                           Increase in notional interest in ADSs following 
        transaction                             the re-investment of dividends paid to 
                                                shareholders on 13 January 2022 on ADSs 
                                                held in the Company's Deferred Annual Bonus 
                                                Plan 
====  =======================================  =================================================== 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  =======================================  =========================  ====================== 
                                               $ 45.0600                  483 
 ============================================  =========================  ====================== 
                                               $ 45.0600                  379 
                                               =========================  ====================== 
                                               $ 45.0600                  287 
                                               =========================  ====================== 
 
 d)    Aggregated information                  1,149 
==== 
 
    Aggregated volume                            $ 45.0600 
    Price 
 ============================================  =================================================== 
 e)    Date of the transaction                 2022-01-17 
====  =======================================  =================================================== 
 f)    Place of the                            New York Stock Exchange (XNYS) 
        transaction 
====  =======================================  =================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                   Mr R Connor 
====  ======================================  ==================================================== 
 b)    Position/status                        President, Vaccines & Global Health 
====  ======================================  ==================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ==================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ==================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 13 January 2022 
                                               on Ordinary Shares held in the Company's 
                                               Deferred Annual Bonus Plan 
====  ======================================  ==================================================== 
 c)    Price(s) and                           Price(s)                    Volume(s) 
        volume(s) 
====  ======================================  ==========================  ====================== 
                                              GBP16.3120                  218 
 ===========================================  ==========================  ====================== 
                                              GBP16.3120                  211 
                                              ==========================  ====================== 
                                              GBP16.3120                  122 
                                              ==========================  ====================== 
 
 d)    Aggregated information                 551 
==== 
 
    Aggregated volume                           GBP16.3120 
    Price 
 ===========================================  ==================================================== 
 e)    Date of the transaction                2022-01-17 
====  ======================================  ==================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                   Ms D Conrad 
====  ======================================  ==================================================== 
 b)    Position/status                        SVP Human Resources 
====  ======================================  ==================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ==================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ==================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 13 January 2022 
                                               on Ordinary Shares held in the Company's 
                                               Deferred Annual Bonus Plan 
====  ======================================  ==================================================== 
 c)    Price(s) and                           Price(s)                    Volume(s) 
        volume(s) 
====  ======================================  ==========================  ====================== 
                                              GBP16.3120                  87 
 ===========================================  ==========================  ====================== 
                                              GBP16.3120                  80 
                                              ==========================  ====================== 
 
 d)    Aggregated information                 167 
==== 
 
    Aggregated volume                           GBP16.3120 
    Price 
 ===========================================  ==================================================== 
 e)    Date of the transaction                2022-01-17 
====  ======================================  ==================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                   Mr J Ford 
====  ======================================  ==================================================== 
 b)    Position/status                        Senior Vice President and General Counsel 
====  ======================================  ==================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ==================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ==================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 13 January 2022 
                                               on Ordinary Shares held in the Company's 
                                               Deferred Annual Bonus Plan 
====  ======================================  ==================================================== 
 c)    Price(s) and                           Price(s)                    Volume(s) 
        volume(s) 
====  ======================================  ==========================  ====================== 
                                              GBP16.3120                  124 
 ===========================================  ==========================  ====================== 
                                              GBP16.3120                  97 
                                              ==========================  ====================== 
 
 d)    Aggregated information                 221 
==== 
 
    Aggregated volume                           GBP16.3120 
    Price 
 ===========================================  ==================================================== 
 e)    Date of the transaction                2022-01-17 
====  ======================================  ==================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================= 
 a)    Name                                    Mr J Ford 
====  =======================================  ==================================================== 
 b)    Position/status                         Senior Vice President and General Counsel 
====  =======================================  ==================================================== 
 c)    Initial notification/                   Initial notification 
        amendment 
====  =======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================= 
 a)    Name                                    GlaxoSmithKline plc 
====  =======================================  ==================================================== 
 b)    LEI                                     5493000HZTVUYLO1D793 
====  =======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================= 
 a)    Description of                          American Depositary Shares ('ADSs') 
        the financial                           ISIN: US37733W1053 
        instrument 
====  =======================================  ==================================================== 
 b)    Nature of the                           Increase in notional interest in ADSs following 
        transaction                             the re-investment of dividends paid to 
                                                shareholders on 13 January 2022 on ADSs 
                                                held in the Company's Deferred Annual Bonus 
                                                Plan 
====  =======================================  ==================================================== 
 c)    Price(s) and                             Price(s)                   Volume(s) 
        volume(s) 
====  =======================================   =========================  ====================== 
                                                $ 45.0600                  41 
                                                =========================  ====================== 
 
 d)    Aggregated information                  N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ========================================  ======================================================== 
 e)    Date of the transaction                 2022-01-17 
====  =======================================  ==================================================== 
 f)    Place of the                            New York Stock Exchange (XNYS) 
        transaction 
====  =======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =========================================================================================== 
 a)    Name                                  Ms S Jackson 
====  =====================================  ==================================================== 
 b)    Position/status                       SVP, Global Communications & CEO Office 
====  =====================================  ==================================================== 
 c)    Initial notification/                 Initial notification 
        amendment 
====  =====================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =========================================================================================== 
 a)    Name                                  GlaxoSmithKline plc 
====  =====================================  ==================================================== 
 b)    LEI                                   5493000HZTVUYLO1D793 
====  =====================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =========================================================================================== 
 a)    Description of                        Ordinary shares of 25 pence each ('Ordinary 
        the financial                         Shares') 
        instrument                            ISIN: GB0009252882 
====  =====================================  ==================================================== 
 b)    Nature of the                         Increase in notional interest in Ordinary 
        transaction                           Shares following the re-investment of dividends 
                                              paid to shareholders on 13 January 2022 
                                              on Ordinary Shares held in the Company's 
                                              Deferred Annual Bonus Plan 
====  =====================================  ==================================================== 
 c)    Price(s) and                          Price(s)                     Volume(s) 
        volume(s) 
====  =====================================  ===========================  ===================== 
                                             GBP 16.3120                  52 
 ==========================================  ===========================  ===================== 
                                             GBP 16.3120                  49 
                                             ===========================  ===================== 
 
 d)    Aggregated information                101 
==== 
 
    Aggregated volume                          GBP 16.3120 
    Price 
 ==========================================  ==================================================== 
 e)    Date of the transaction               2022-01-17 
====  =====================================  ==================================================== 
 f)    Place of the                          London Stock Exchange (XLON) 
        transaction 
====  =====================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                    Mr B McNamara 
====  =======================================  =================================================== 
 b)    Position/status                         CEO, GSK Consumer Healthcare 
====  =======================================  =================================================== 
 c)    Initial notification/                   Initial notification 
        amendment 
====  =======================================  =================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                    GlaxoSmithKline plc 
====  =======================================  =================================================== 
 b)    LEI                                     5493000HZTVUYLO1D793 
====  =======================================  =================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                          American Depositary Shares ('ADSs') 
        the financial                           ISIN: US37733W1053 
        instrument 
====  =======================================  =================================================== 
 b)    Nature of the                           Increase in notional interest in ADSs following 
        transaction                             the re-investment of dividends paid to 
                                                shareholders on 13 January 2022 on ADSs 
                                                held in the Company's Deferred Annual Bonus 
                                                Plan 
====  =======================================  =================================================== 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ---------------------------------------  =========================  ====================== 
                                               $ 45.0600                  81 
 --------------------------------------------  =========================  ====================== 
                                               $ 45.0600                  69 
                                               =========================  ====================== 
                                               $ 45.0600                  87 
                                               -------------------------  ---------------------- 
 
 
 d)    Aggregated information                  237 
==== 
 
    Aggregated volume                            $ 45.0600 
    Price 
 ============================================  =================================================== 
 e)    Date of the transaction                 2022-01-17 
====  =======================================  =================================================== 
 f)    Place of the                            New York Stock Exchange (XNYS) 
        transaction 
====  =======================================  =================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                   Mr L Miels 
====  ======================================  ==================================================== 
 b)    Position/status                        Chief Commercial Officer 
====  ======================================  ==================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ==================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ==================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 13 January 2022 
                                               on Ordinary Shares held in the Company's 
                                               Deferred Annual Bonus Plan 
====  ======================================  ==================================================== 
 c)    Price(s) and                           Price(s)                    Volume(s) 
        volume(s) 
====  ======================================  ==========================  ====================== 
                                              GBP16.3120                  232 
 ===========================================  ==========================  ====================== 
                                              GBP16.3120                  202 
                                              ==========================  ====================== 
                                              GBP16.3120                  151 
                                              ==========================  ====================== 
 
 d)    Aggregated information                 585 
==== 
 
    Aggregated volume                           GBP16.3120 
    Price 
 ===========================================  ==================================================== 
 e)    Date of the transaction                2022-01-17 
====  ======================================  ==================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                   Mr D Redfern 
====  ======================================  ==================================================== 
 b)    Position/status                        Chief Strategy Officer 
====  ======================================  ==================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ==================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ==================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 13 January 2022 
                                               on Ordinary Shares held in the Company's 
                                               Deferred Annual Bonus Plan 
====  ======================================  ==================================================== 
 c)    Price(s) and                           Price(s)                    Volume(s) 
        volume(s) 
====  ======================================  ==========================  ====================== 
                                              GBP16.3120                  206 
 ===========================================  ==========================  ====================== 
                                              GBP16.3120                  148 
                                              ==========================  ====================== 
                                              GBP16.3120                  118 
                                              ==========================  ====================== 
 
 d)    Aggregated information                 472 
==== 
 
    Aggregated volume                           GBP16.3120 
    Price 
 ===========================================  ==================================================== 
 e)    Date of the transaction                2022-01-17 
====  ======================================  ==================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                   Mr R Simard 
====  ======================================  ==================================================== 
 b)    Position/status                        President, Pharmaceuticals Supply Chain 
====  ======================================  ==================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ==================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ==================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 13 January 2022 
                                               on Ordinary Shares held in the Company's 
                                               Deferred Annual Bonus Plan 
====  ======================================  ==================================================== 
 c)    Price(s) and                           Price(s)                    Volume(s) 
        volume(s) 
====  ======================================  ==========================  ====================== 
                                              GBP16.3120                  74 
 ===========================================  ==========================  ====================== 
                                              GBP16.3120                  105 
                                              ==========================  ====================== 
                                              GBP16.3120                  89 
                                              ==========================  ====================== 
 
 d)    Aggregated information                 268 
==== 
 
    Aggregated volume                           GBP16.3120 
    Price 
 ===========================================  ==================================================== 
 e)    Date of the transaction                2022-01-17 
====  ======================================  ==================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                   Mr P Thomson 
====  ======================================  ==================================================== 
 b)    Position/status                        President, Global Affairs 
====  ======================================  ==================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ==================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument                             ISIN: GB0009252882 
====  ======================================  ==================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 13 January 2022 
                                               on Ordinary Shares held in the Company's 
                                               Deferred Annual Bonus Plan 
====  ======================================  ==================================================== 
 c)    Price(s) and                           Price(s)                    Volume(s) 
        volume(s) 
====  ======================================  ==========================  ====================== 
                                              GBP16.3120                  120 
 ===========================================  ==========================  ====================== 
                                              GBP16.3120                  85 
                                              ==========================  ====================== 
                                              GBP16.3120                  69 
                                              ==========================  ====================== 
 
 d)    Aggregated information                 274 
==== 
  Aggregated volume                           GBP16.3120 
   Price 
 ===========================================  ==================================================== 
 e)    Date of the transaction                2022-01-17 
====  ======================================  ==================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                   Ms D Waterhouse 
====  ======================================  ====================================================== 
 b)    Position/status                        Chief Executive Officer of ViiV Healthcare 
====  ======================================  ====================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ====================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ====================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ====================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ====================================================== 
 b)    Nature of the                          Increase in notional interest in Ordinary 
        transaction                            Shares following the re-investment of dividends 
                                               paid to shareholders on 13 January 2022 
                                               on Ordinary Shares held in the Company's 
                                               Deferred Annual Bonus Plan 
====  ======================================  ====================================================== 
 c)    Price(s) and                            Price(s)                     Volume(s) 
        volume(s) 
====  ======================================   ===========================  ====================== 
   GBP16.3120                                                               142 
   =======================================================================  ====================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ====================================================================  ============================= 
 e)    Date of the transaction                2022-01-17 
====  ======================================  ====================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ====================================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHEKLFFLFLBBBQ

(END) Dow Jones Newswires

January 19, 2022 10:10 ET (15:10 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2022 to May 2022 Click Here for more Gsk Charts.
Gsk (LSE:GSK)
Historical Stock Chart
From May 2021 to May 2022 Click Here for more Gsk Charts.